MolNFT v1 · #124389 · protein
Structure of the human GLUN1/GLUN2A lbd in complex with GNE0723
5KDT: “Structure of the human GLUN1/GLUN2A lbd in complex with GNE0723”. X-ray diffraction, 1 ligand (6RV). MolNFT v1 #124389 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5KDT
- Type
- protein
- Length
- 564 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- Q12879, Q05586
- Ligands
- 6RV
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 279 | — | Q12879 |
| B | — | protein | 285 | — | Q05586 |
Ligands and binding sites
- 6RV · (1~{R},2~{R})-2-[7-[[5-chloranyl-3-(trifluoromethyl) pyrazol-1-yl]methyl]-5-oxidanylidene-2-(trifluoromethyl)-[1,3]thiazolo[3,2-a]pyrimidin-3-yl]cyclopropane-1-carbonitrile · ligand · chains A, B
- ACT · Acetate ion · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 5KDT · Structure of the human GluN1/GluN2A LBD in complex with GNE0723 · the same entry in another collection · chain B against B, TM-score 1.00
- Q12879 · AlphaFold monomer V2.0 prediction for glutamate receptor ionotropic, NMDA 2A (Q12879) · a predicted model of the same protein · chain A against A, TM-score 0.98
- Q05586 · AlphaFold monomer V2.0 prediction for glutamate receptor ionotropic, NMDA 1 (Q05586) · a predicted model of the same protein · chain B against A, TM-score 0.96
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q12879
- Every structure of UniProt Q05586
- Elsewhere: RCSB PDB 5KDT · PDBe 5KDT · UniProt Q12879 · UniProt Q05586
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.